The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism.EBI
Peking Union Medical College and Chinese Academy of Medical Sciences
Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2.EBI
Kunming Institute of Botany
Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential ?-glucosidase and SARS-CoV-2 entry inhibitors.EBI
Zhengzhou University
Identification, optimization, and biological evaluation of 3-O-?-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein.EBI
South China Agricultural University
Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins.EBI
Keio University
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.EBI
University of California San Diego
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.EBI
University of Groningen
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization.EBI
University of Salerno
Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.EBI
Second Military Medical University
Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2.EBI
University of Toronto
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.EBI
University of California San Francisco (Ucsf)
Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of EBI
Chinese Academy of Sciences